Project Details
Description
A cell therapy for lung cancer that can fill a niche between anti-PD1 therapies and current targeted therapies, which often become resistant. It uses low dosages of exosomes to treat lung cancer and eliminate the need for toxic drugs while being affordable and accessible to the general public.
| Status | Finished |
|---|---|
| Effective start/end date | 8/1/23 → 7/31/24 |
Keywords
- Encapsulated cell therapy (ECT)
- Microtube array membranes (MTAMs)
- Drug delivery
- Lung cancer
- Exosomes
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.